These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6860416)

  • 1. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.
    Powell SH; Thompson WL; Luthe MA; Stern RC; Grossniklaus DA; Bloxham DD; Groden DL; Jacobs MR; DiScenna AO; Cash HA; Klinger JD
    J Infect Dis; 1983 May; 147(5):918-32. PubMed ID: 6860416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside nephrotoxicity in dogs: dependence on drug, dose and regimen.
    Thompson WL; Powell S
    Scand J Infect Dis Suppl; 1980; Suppl 23():91-5. PubMed ID: 6937972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between rat renal accumulation of gentamicin, tobramycin, and netilmicin and their nephrotoxicities.
    Brier ME; Mayer PR; Brier RA; Visscher D; Luft FC; Aronoff GR
    Antimicrob Agents Chemother; 1985 May; 27(5):812-6. PubMed ID: 4015072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netilmicin and tobramycin. Comparison of nephrotoxicity in dogs.
    Engle JE; Abt AB; Schneck DW; Schoolwerth AC
    Invest Urol; 1979 Sep; 17(2):98-102. PubMed ID: 468518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aminoglycosides in patients with mucoviscidosis and pulmonary exacerbation. Comparison of once or three times daily administration].
    Heininger U; Böwing B; Stehr K; Solbach W
    Klin Padiatr; 1993; 205(1):18-22. PubMed ID: 8445848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative toxicity of intravitreal aminoglycoside antibiotics.
    D'Amico DJ; Caspers-Velu L; Libert J; Shanks E; Schrooyen M; Hanninen LA; Kenyon KR
    Am J Ophthalmol; 1985 Aug; 100(2):264-75. PubMed ID: 4025468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches for the use of aminoglycosides: the value of experimental models.
    Kapusnik JE; Sande MA
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():7-10. PubMed ID: 3710965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative toxicity of netilmicin and tobramycin in dogs.
    Szot RJ; McCormick G; Chung M; Christie B; Weinberg E; Schwartz E
    Toxicol Appl Pharmacol; 1980 Aug; 55(1):169-78. PubMed ID: 7423502
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenging conventional aminoglycoside dosing regimens. The value of experimental models.
    Kapusnik JE; Sande MA
    Am J Med; 1986 Jun; 80(6B):179-81. PubMed ID: 3089001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical toxicologic studies of netilmicin.
    Weinberg EH; Field WE; Gray WD; Klein MF; Robbins GR; Schwartz E
    Arzneimittelforschung; 1981; 31(5):816-22. PubMed ID: 7196743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative nephrotoxicities of high-dose netilmicin and tobramycin in rats.
    Parker RA; Gilbert DN; Houghton DC; Porter GA; Bennett WM
    Antimicrob Agents Chemother; 1980 Aug; 18(2):346-8. PubMed ID: 7447411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides.
    Young DC; Zobell JT; Stockmann C; Waters CD; Ampofo K; Sherwin CM; Spigarelli MG
    Pediatr Pulmonol; 2013 Nov; 48(11):1047-61. PubMed ID: 24000183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of tobramycin- and netilmicin-induced ototoxicity in guinea pigs with evoked action potentials.
    Bernard PA; Pechere JC; Jequier JC
    J Infect Dis; 1979 Apr; 139(4):418-23. PubMed ID: 438542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative ototoxicity of amikacin, gentamicin, netilmicin, and tobramycin in guinea pigs.
    Parravicini L; Arpini A; Bamonte F; Marzanatti M; Ongini E
    Toxicol Appl Pharmacol; 1982 Sep; 65(2):222-30. PubMed ID: 7179282
    [No Abstract]   [Full Text] [Related]  

  • 16. The nephrotoxic potential of netilmicin as determined in a rat model.
    Luft FC
    Scand J Infect Dis Suppl; 1980; Suppl 23():82-90. PubMed ID: 6937971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs.
    Chung M; Parravicini L; Assael BM; Cavanna G; Radwanski E; Symchowicz S
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1017-21. PubMed ID: 7159067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Bhatt J
    Cochrane Database Syst Rev; 2012 Feb; (2):CD002009. PubMed ID: 22336782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.